Mechanism
4
1
1
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
2 treatments under study, led by Transjugular Intrahepatic Portosystemic Shunt
Research Leaders
6 sponsors active, led by Heilongjiang University of Chinese Medicine
Related Conditions
Often studied with 10 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 4 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (4)
Mechanism of TIPS to Improve Sarcopenia
Changes in Body Composition of Patients With Obesity Related Tumors and Their Impact on Clinical Outcomes: a Multicenter Prospective Cohort Study
Effect and Mechanism of Jiajian Guishen Formulation on Premature Ovarian Insufficiency Based on Metabolomics
Proteomics/Modifier Based on Mass Spectrometry Reveals the Pathogenesis of Eclampsia During Pregnancy and the Screening of Disease Markers
Research Network
Common Treatments
- Transjugular Intrahepatic Portosystemic Shunt1
- Jiajian Guishen Formulation1
Active Sponsors
- Heilongjiang University of Chinese Medicine1
- The First Affiliated Hospital of Zhengzhou University1
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology1
- The First Affiliated Hospital of Henan University of Science and Technology1
- Peking Union Medical College Hospital1
Top Investigators
Dongzhimen Hospital of Beijing University of Chinese Medicine
Dongzhimen Hospital of Beijing University of Chinese Medicine
Dongzhimen Hospital of Beijing University of Chinese Medicine
Dongzhimen Hospital of Beijing University of Chinese Medicine
Dongzhimen Hospital of Beijing University of Chinese Medicine
Related Conditions
- Survival1
- Body Composition Changes1
- Traditional Chinese Medicine1
- Clinical Syndrome1
- Obesity Rekated Cancer1